After Mind Medicine’s very successful International Summit on Psychedelic Therapies for Mental Illness, I’m sure the nascent industry is ablaze with ideas and inspiration. The down-scheduling decision on MDMA and psilocybin is due to be released in Dec 2021, and one of the last things we were asked to do as participants of the summit…
“Reducing stigma, saving lives” is the final blog in the 10 blog series on overdose awareness and overdose prevention topics. Did you miss the latest overdose research and overdose statistics report, released on the 31st of August 2021 (International Overdose Awareness Day)? The 2021 overdose research report was compiled and published by John Ryan and…
Glancing at headlines these days there appears to be a consistent stream of positive news breaking out all over the world about the potential therapeutic benefits of psychedelics, including a declaration from the FDA that psilocybin is a “breakthrough therapy.” Australia has also been involved in conducting some of the research and there are ongoing…
The latest Australian overdose statistics (2021) This is blog 9 of 10 blogs in the overdose awareness and overdose prevention series. The 31st of August is International Overdose Awareness Day. We had the privilege of interviewing the Penington Institute’s CEO, John Ryan, about the latest Australian overdose statistics revealed in the Penington Institute’s 2021 Australian…
Drug safety monitoring and overdose prevention This is part of the overdose statistics blog series (overdose awareness and overdose prevention articles). Drug safety monitoring is an important part of GMP/GxP compliance. Drug safety monitoring includes pharmacovigilance as well as supply chain protection. These safety measures can help prevent product diversions, and reduce product overdose risks,…
Please complete the form on the contact us page. We will get back to you within one business day.
Phone: +61 3 9887 6412
Email: info@pharmout.net
